39 results about "Biologic treatment" patented technology

Provided are a household toilet waste treatment system and a method of treating toilet waste using the same, the household toilet waste treatment system comprising a solid-liquid separation toilet, a biological treatment apparatus, a sterilization apparatus, and a combustion apparatus. The combustion apparatus complements a slow biological treatment apparatus to allow continuous treatment of the household toilet waste in a unit space without long-distance piping connections.

The application discloses a high-salt-tolerant protease-producing Arthrobacter protophormiae and application thereof, and belongs to the technical field of environmental microorganisms.The application provides the Arthrobacter protophormiae A1 which is preserved in the China Center for Type Culture Collection on May 23, 2024, and the preservation number is CCTCC NO: M 20241041.The Arthrobacter protophormiae provided by the application can tolerate 8.0% salinity, and can effectively secrete protease under high-salt stress.The bacteria can provide effective strain resources for the anaerobic biological treatment of reinforced kitchen waste and other high-salt high-protein waste water, thereby significantly reducing the treatment cost, and have important application value.

To provide a biological treatment system, a biological treatment apparatus, a water purification system, a biological treatment method and a water purification method that are excellent in the efficiency and stability of biological treatment.SOLUTION: A biological treatment system comprises: a tank 1 containing a mixture of an object to be biologically treated and microorganisms; a monitoring unit 2 that monitors an index of a microbial concentration of the mixture; an adjustment unit 3 that adjusts the microbial concentration of the mixture; and a control unit 4 that controls the adjustment unit based on monitoring results of the index of the microbial concentration.SELECTED DRAWING: Figure 1

The invention discloses a pharmaceutical wastewater treatment all-in-one machine and a treatment process thereof, and relates to the technical field of wastewater treatment.The pharmaceutical wastewater treatment all-in-one machine comprises a bottom plate, the left side of the upper portion of the bottom plate is fixedly connected with a coagulation reaction assembly through a support, and a precipitation assembly is installed on the right side of the coagulation reaction assembly above the bottom plate through a support; a biological treatment assembly is arranged on the upper surface of the bottom plate on the right side of the precipitation assembly, and at least three groups of deep adsorption assemblies are mounted on the upper surface of the bottom plate on the right side of the biological treatment assembly. The system has the advantages that the occupied area is reduced, complex pipeline connection is not needed, and the system adapts to hospitals, small pharmaceutical enterprises and other limited sites; all the components are sequentially and tightly arranged along the wastewater treatment process, wastewater can directly flow in the equipment, pipeline leakage and secondary pollution are avoided, meanwhile, flow and liquid level synchronous control is achieved through an internal structure, wastewater treated in the previous procedure can directly enter a subsequent unit, and the treatment efficiency is improved.

The application provides an electro-catalysis system applied to an anaerobic biological treatment technology, an electrode assembly and application. The electrode assembly comprises an electrode frame, a plurality of cathode electrode plates and a plurality of anode electrode plates. The cathode electrode plates and the anode electrode plates are fixed on the electrode frame at intervals. A plurality of electro-catalysis fillers are arranged at intervals along the height direction of the cathode electrode plates and the anode electrode plates. The electro-catalysis fillers are made of a plurality of "8" type woven products around a center rope. The "8" type woven product is made of modified carbon fiber filaments and a nylon wire framework. The electro-catalysis filler made of the modified carbon fiber filaments can guarantee the strength of the filler, greatly reduce the use amount of carbon materials, reduce the cost and have good corrosion resistance. Since the carbon fiber material has excellent specific surface area, the amount of microorganisms can be enriched, and the efficiency of electron transfer can be improved. Since the nylon wire framework is adopted for support, the form of the filler is guaranteed, and efficient operation of the electro-catalysis reaction is guaranteed.

The present disclosure relates to a valve block (100) for controlling fluid flow into or out of a solution management system (200) for biological treatment, the valve block being a single unit and comprising: at least one inlet port (10); at least one outlet port (20); and four or more valve sections (30) fluidly connected to the at least one inlet port and the at least one outlet port, each valve section configured to receive a valve element (32) for controlling fluid passing through the valve block; wherein the at least two valve sections are fluidically connected to each other by means of an integrally formed first channel (40), which changes direction twice or more.

A novel portable, and attachable device allows precise positioning of micro-tissues, tumor spheroids, and other biological samples during bioprinting. The device features an interchangeable connector for handling samples of various sizes and uses a manually adjustable pressure system for suction and deposition. A programmable control unit coordinates pressure and positioning based on input commands, enhancing accuracy and consistency in tissue handling. Compatible with multiple bioprinter systems and supporting both manual and automated operation, it streamlines workflows and improves user experience. This device addresses challenges in high-throughput biological positioning, critical for tissue engineering, clinical, pharmaceutical, and research applications. It supports advancements in customized medicine, biological models, and environmental monitoring, meeting the growing demand for precise biologic handling in the multi-billion-dollar bioprinting and biopsy markets. The device offers superior control over tissue biopsy positioning compared to current manual devices reliant on operator skill.

A liquid-actuated pump (100, 200, 300, 400) for a biological treatment system, the pump (100, 200, 300, 400) comprising: a pump chamber (130, 230, 330); a flexible diaphragm (132) configured to form a barrier between a control liquid portion (136) of the pump chamber (130, 230, 330) and a process fluid portion (134) of the pump chamber (130, 230, 330); a process fluid flow path (110, 210, 310) including a process fluid portion (134) of the pump chamber (130, 230, 330); and a control liquid flow path (120, 220) comprising: an inlet (122) to the pump (100, 200, 300, 400); an outlet (124) from the pump (100, 200, 300, 400); and a control liquid portion (136) of the pump chamber (130, 230, 330); wherein the control fluid flow path (120, 220) is configured to contain at least a portion of the control fluid of the trapped volume, and wherein displacement of the control fluid of the trapped volume causes deformation of the flexible diaphragm (132), the deformation of the flexible diaphragm (132) causing movement of the process fluid in the process fluid flow path (110, 210, 310).

A biological treatment system comprising a central control unit (1); at least two biological treatment units (2a, 2b) wherein each of the at least two biological treatment units comprises at least one flow path (3a, 3b) comprising an inlet (4a, 4b) and an outlet (5a, 5b), at least two selected biological treatment units of the at least two biological treatment units are connected in series by a fluid connection (6) of an outlet of an upstream biological treatment unit (2a) of the two selected biological treatment units and an inlet (4b) of a downstream biological treatment unit (2b) of the two selected biological treatment units, therefore, a line of at least two biological treatment units which are connected in series is formed; a client control module (7a, 7b) of each of the at least two biological treatment units, where each client control module is connected to the central control unit, and where each client control module is configured to interact with a biological treatment unit connected to the client control module; and a transfer module (8) associated with each fluid connection (6) between each of said at least two selected biological treatment units in a line of at least two biological treatment units connected in series, wherein each of the transfer modules (8) comprises an upstream set of parameters characterizing an upstream biological treatment unit of each fluid connection (6) and a downstream set of parameters characterizing a downstream biological treatment unit (2b) of each fluid connection, the upstream set of parameters comprising at least an upstream state parameter characterizing a state of the upstream biological treatment unit (2a), and the downstream set of parameters characterizing a state of the downstream biological treatment unit (2b). The downstream parameter set at least comprises downstream state parameters representing the state of the downstream biological treatment unit; and wherein each of the transfer modules (8) comprises at least one algorithm to calculate a decision statement from the upstream and / or downstream set of parameters, wherein the decision statement comprises adjusting a flow rate of a fluid in a fluid connection (6) associated with the transfer module (8).

The utility model provides a gas circuit assembly, an alternate tangential flow device and a perfusion system, and relates to the technical field of biological treatment and pharmacy, the gas circuit assembly provided by the utility model comprises a negative pressure container, a control device, a first vacuum pump and at least one second vacuum pump, the negative pressure container is provided with a negative pressure output pipeline; the first vacuum pump and the at least one second vacuum pump are in fluid communication with the negative pressure container through gas pipelines; and the control device is connected with the negative pressure container and controls the at least one second vacuum pump to start when the internal pressure of the negative pressure container exceeds a preset value. The negative pressure state in the negative pressure container can be ensured to be stable and continuous when the power of the first vacuum pump is insufficient or the first vacuum pump is shut down due to failure, the negative pressure suction device is particularly suitable for providing negative pressure suction for a plurality of ATF system assemblies, and the reliability of the alternate tangential flow device can be improved.

A method of treating a psoriasis plaque subject who has previously been treated with a biological agent, comprising administering to the subject an effective amount of an anti-IL-23p19 subunit antibody, and to the use of an anti-IL-23p19 antibody to treat a psoriasis plaque subject who has previously been treated with a biological agent.

The disclosed technology provides an alternative means of efficient sterilization when transferring sterile media or axenic culture, or when sterilizing media for a bioprocess. Some variations provide a process interconnection comprising: a first process valve; a second process valve in flow communication with the first process valve; a process chamber in flow communication, and interposed between, the first and second process valves; and one or more UV light sources configured to expose ultraviolet light to at least 99% of chamber internal surface area and to at least 99% of valve internal surface area. Some variations provide a system for bioprocessing that utilizes the process interconnection. Other variations provide a system for sterilizing bioprocessing media. Various methods of using the disclosed systems are also disclosed in detail. These include methods of sterile material transfer, methods of axenic culture transfer, methods of sterile bioprocessing, and methods of sterilizing bioprocessing media.

The invention relates to a method for performing a bioprocess on immune or naive cell culture(s) to obtain processed cell culture(s) on a semi-automated bioprocessing system (1), comprising a primary workstation (2) and performing a workflow, the workflow comprising a plurality of unit operations performed by the primary workstation (2), wherein the primary workstation (2) comprises a unit operation interface (4), wherein the unit operations are performed by an interaction of the unit operation interface (4) with at least one cartridge (5), wherein a first unit operation (16) and a second unit operation (17) of the plurality of unit operations are performed by the unit operation interface (4) with different cartridge configurations (13), wherein between the first and the second unit operation (16, 17) the cartridge configuration (13) is manually reconfigured in a reconfiguration step, wherein the manual reconfiguration in the reconfiguration step is supported by the bioprocessing system (1).

The present invention relates to an integrated bioprocessing system for performing several bioprocesses on a liquid immunocellular cell culture or naive cell culture, wherein the integrated bioprocessing system (1) performs several different bioprocesses by following different protocols, the protocols defining the actions that the integrated bioprocessing system (1) performs on the cell culture for each bioprocess, the integrated bioprocessing system (1) detects at least one state of the cell culture via a sensor (6), the protocols defining the reactions performed by the integrated bioprocessing system (1) when the state of the cell culture deviates from the normal state defined in the protocol, and the integrated bioprocessing system (1) detects at least one state of the integrated bioprocessing system (1), particularly via a sensor (6). It is proposed that the protocols define the reactions performed by the integrated bioprocessing system (1) when the state of the integrated bioprocessing system (1) deviates from the normal state defined in the protocol.

A biological treatment system for performing a biomanufacturing process is provided. In one embodiment, a system includes a single-use bag configured to perform a biological treatment operation using at least one port welded to the single-use bag. The at least one port has a channel for providing a fluid pathway to an interior volume of the disposable bag. The system also includes at least one mating ring. The at least one port includes a first feature configured to engage with a corresponding second feature of the at least one mating ring such that the at least one mating ring can be locked to the at least one port. The mating rings and bag ports are configured to provide a range of structural functionalities to facilitate assembly and use of the biological treatment system.

The utility model relates to the technical field of tail water treatment, and discloses a biological treatment device for breeding tail water, which comprises a water pipe and an aeration tank, one end of the water inlet pipe is fixedly connected with a grit chamber, the inner wall of the grit chamber is fixedly connected with a liquid flowing plate, the outer wall of the grit chamber is fixedly connected with a drain pipe, one end of the drain pipe is provided with an oxygen supply component, and the other end of the drain pipe is provided with a water outlet. A one-way valve assembly is arranged on the outer wall of the aeration tank; the one-way valve assembly comprises a fourth connecting pipe, the side wall of the fourth connecting pipe is fixedly connected to the outer wall of the aeration tank, one end of the fourth connecting pipe is fixedly connected with an annular column, and the inner wall of the annular column is fixedly connected with a fixing plate. According to the biological treatment device, the fixing column is driven by the sealing plug to move, the spring on the outer wall is contracted by the fixing column, and the fixing column slides in the lantern ring, so that the effect of a one-way valve is achieved, the problem that when the device is stopped due to the absence of the one-way valve, liquid flows back and is mixed is solved, and the stability of the biological treatment device is improved.

The invention relates to a low-salt-content polypeptide production method, and belongs to the technical field of polypeptide production. The method comprises the following steps: removing surface meat and grease from cattle bones, sheep bones and pig bones, cleaning, carrying out multi-stage crushing to prepare crushed bones, soaking the crushed bones in a microbial bacteria solution to play a biological treatment role, further adding acid, citric acid, acetic acid and hydrochloric acid with different strengths, carrying out gradient acid pickling, and finally carrying out protease enzymolysis to obtain the high-protein protein powder. And performing spray drying to obtain a finished product of the low-salt-content polypeptide. The low-salt-content polypeptide obtained through recycling of the soup, microbiological treatment, multi-stage pickling and mild enzymolysis is high in quality, low in salt content and sufficient in extraction.

A preparation kit and method for reconstituting and delivering biologic treatments derived from human umbilical cord and amniotic membrane tissue. The kit includes a vial containing lyophilized biologic material, a removable seal, and a spray nozzle with a removable cap to maintain sterility. A container holds a humectant solution comprising glycerol, hyaluronic acid, or a combination thereof. In use, the humectant solution is added to the vial, the biologic material is mixed, and the spray nozzle is used for aesthetic application to human skin or hair. The vial is made of glass or medical-grade plastic to prevent contamination. The spray nozzle delivers a measured dose ranging from 0.5 mL to 5 mL. The method involves removing the seal, adding the humectant solution, attaching the spray nozzle, mixing the components, and applying the biologic via spray.

Method for performing a bioprocess on liquid immune cell cultures comprising a sequence of processing steps, wherein the bioprocess is being performed on an integrated bioprocessing system, wherein the sequence of processing steps comprises at least one unit operation, which is being performed within a unit operation station of the integrated bioprocessing system. Cartridges, that have been preconfigured with a cartridge fluidic structure with respect to the respective unit operation, are being stored in a cartridge storage unit of the unit operation station and that for performing the respective unit operation, one of the cartridges is being transported from a storage transfer location in a cartridge storage unit of the unit operation station to a drive location of a cartridge drive unit of the unit operation station by a local transport mechanism of the unit operation station and is being brought into operative coupling with the cartridge drive unit.

According to an embodiment, a plasma treatment system for microorganisms includes a plasma generation unit that generates a reactive gas through plasma discharge; a microorganism treatment unit that includes a chamber having an internal space for accommodating a culture medium containing microorganisms, an inlet that injects the reactive gas from the plasma generation unit, and an outlet for discharging gas generated in the internal space, wherein the microorganism treatment unit includes a sparger that disperses the reactive gas supplied through the inlet in the form of bubbles, and a blade that agitates the culture medium within the chamber, and the sparger and the blade are disposed adjacent to a bottom surface of the chamber.

The invention relates to an aeration device for a biological treatment plant (2), comprising a housing (4), a circumferentially rigid body (5), where the housing (4) comprises at least a first aeration channel (7) and a second aeration channel (8), where the housing (4) further comprises at least a first gas inlet port (10) and a second gas inlet port (11), and where the gas inlet port (11) and the gas inlet port (11) are connected to each other. The housing (4) further comprises a plurality of first gas discharge openings (12) and second gas discharge openings (13). It is proposed that the first aeration channel (7) and the second aeration channel (8) are arranged so as to overlap one another at least in sections in the axial direction.

A biological treatment bag for accommodating and protecting fluids involved in a biological treatment process, the biological treatment bag comprising: at least two films bonded together along edges to form a bag body; and a fluid port through which fluid can flow into or out of the bag body; wherein at least one of said films is a band-stop film, said band-stop film comprising a band-stop layer, characterized in that at least a portion of said band-stop layer has electromagnetic (EM) transmission characteristics that block the transmission of electromagnetic radiation within a selected electromagnetic bandwidth, said electromagnetic radiation being likely to be encountered in the ambient environment in which the biological treatment bag is in operation, and the biological treatment liquid to be accommodated in the biological treatment bag is harmful.

A method for removing NOx gases from a gas stream, which includes:i) contacting the gas stream with a solvent system which comprises a non-aqueous phase liquid (NAP) that is capable of acting as NOx gas-liquid mass transfer vector; andii) subjecting the solvent system of step i) to microbial denitrification, wherein NOx is selected from nitric oxide (NO), nitrogen dioxide (NO2), and a mixture thereof. The NAP has a molecular weight from 150 to 550 g / mol and a boiling point from 400 to 700 K. The use of the NAP for removing NOx gases from a gas stream.

The present invention covers and / or separates one or more aqueous reaction mixtures in a reaction vessel using a gel layer. The gel layer can protect a reagent or a reaction product from being in contact with the atmosphere. The gel layer may also separate a plurality of aqueous reaction mixtures such that they do not contact each other before the gel layer breaks. The oil layer can be directly inserted under the gel layer. By inserting the tip of the micropipettor, a solution (such as a sample) can be delivered below the gel layer through the gel layer. A micropipette tip or inert rod may also be used to break the gel layer resulting in mixing of the aqueous reaction mixture above and below the layer. The gel layer may also be ruptured by selectively applying heat or moving the magnetic beads. A plurality of gel layers separating a plurality of aqueous reagent mixtures may be ruptured in a prescribed order to perform a series of ordered biological treatment steps.

The utility model discloses a flue gas microbiological treatment device which comprises an outer cylinder, a bottom plate, a partition plate and a microbiological filler box, the outer cylinder is a cylinder body fixed in a tower body of the flue gas microbiological treatment tower; the bottom plate is fixed in the outer cylinder; the partition plates are arranged on a bottom plate in the outer cylinder and divide the interior of the outer cylinder into a plurality of filler cavities, and drawer openings communicated with the corresponding filler cavities are formed in the side wall of the outer cylinder and correspond to the filler cavities; a through hole communicated with the corresponding filler cavity is formed in the bottom plate and corresponds to each filler cavity; the microorganism filler boxes are a plurality of hollow box bodies which are in one-to-one correspondence with the filler cavities and can be pushed into or pulled out of the filler cavities from the corresponding drawer openings, microorganism filler inoculated with microorganisms is filled in the microorganism filler boxes, and the box walls, located in the filler cavities, of the microorganism filler boxes are of hollow net plate-shaped structures; and the box wall positioned at the drawer opening is of a solid plate-shaped structure for blocking the drawer opening. The cleaning device is easy to operate, high in cleaning efficiency and good in safety.

A fluid bed type biological treatment device and a method for operating the same, the fluid bed type biological treatment device comprising: a tank (2) in which a fluid carrier (C) is housed; the screen (7) is arranged in the tank body (2) and is used for separating the carrier and guiding treated water to a discharge port; a partition plate (8) that partitions the inside of the tank body (2) into a rectification region in which the screen (7) is disposed and a reaction region in which biological treatment is performed; an air diffusion member (9) for causing air bubbles to flow along the surface of the rectifying region side of the screen (7); and an opening (11) which is provided in the upper part of the partition plate (8) and through which a carrier passes from the rectification region to the reaction region.

This invention belongs to the technical field of biological treatment of formaldehyde pollution, and discloses a formaldehyde superoxide dismutase, its preparation method, strain, device, application, and formaldehyde treatment method. The amino acid sequence of the formaldehyde superoxide dismutase provided by this invention is shown in SEQ ID NO:1 or a variant sequence having at least 99% homology with the sequence shown in SEQ ID NO:1. This formaldehyde superoxide dismutase has excellent biological activity in degrading formaldehyde and can be well applied in formaldehyde pollution treatment to achieve ideal formaldehyde degradation effect.

The application provides a method for identifying microbial metabolic molecular markers in a biological treatment process, comprising: determining a plurality of organic molecules of microbial metabolites in a preset molecular mass range from a target biological treatment process by using high-resolution mass spectrometry; pairing each two organic molecules to form a plurality of organic molecule pairs; screening a first target organic molecule pair from the plurality of organic molecule pairs according to first molecular mass difference information and second molecular mass difference information, wherein the first molecular mass difference information is determined according to the organic molecule pair, and the second molecular mass difference information is determined according to a whole genome and a metabolic pathway database; constructing a preset network according to the first target organic molecule pair, wherein the preset network comprises a plurality of nodes; screening a target node from the plurality of nodes according to a preset condition; and determining a microbial metabolic molecular marker in the target biological treatment process according to the target node.

The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.